Your activity: 12 p.v.

Etiology and diagnosis of tinnitus

Etiology and diagnosis of tinnitus
Author:
Elizabeth A Dinces, MD
Section Editor:
Daniel G Deschler, MD, FACS
Deputy Editor:
Jane Givens, MD, MSCE
Literature review current through: Dec 2022. | This topic last updated: Sep 29, 2022.

INTRODUCTION — Tinnitus is a perception of sound in proximity to the head in the absence of an external source. It can be perceived as being within one or both ears, within or around the head, or as an outside distant noise. The sound is often a buzzing, ringing, or hissing, although it can also sound like other noises.

Tinnitus can be continuous or intermittent. Although both may have a significant impact on the patient, the latter is not usually related to a serious underlying medical problem. The sound may be pulsatile or non-pulsatile. Pulsatile tinnitus raises more concern for underlying significant pathology, though non-pulsatile tinnitus may also be associated with underlying disease.

The epidemiology, pathogenesis, and diagnosis of tinnitus will be reviewed here. The treatment of tinnitus is discussed separately. (See "Treatment of tinnitus".)

EPIDEMIOLOGY — According to the American Tinnitus Association, an estimated 50 million people in the United States have chronic tinnitus, persisting for greater than six months [1]. For 12 million, it is severe enough to interfere with daily activities. These people are effectively disabled by their tinnitus to varying degrees.

Tinnitus can occur in children [2] and increases with age [3,4]. Tinnitus is more common in men than in women and is more likely to occur among individuals who smoke [1].

CLINICAL IMPACT — The impact of tinnitus on an individual can be significant. Some individuals "experience" tinnitus, while others "suffer from it." Overall, about 25 percent of tinnitus sufferers report an increase in tinnitus severity over time [5]. Chronic tinnitus is unlikely to remit completely but often becomes less bothersome over time, especially in the setting of hearing loss.

The impact of tinnitus can be consistently measured by two outcome instruments: the Tinnitus Handicap Inventory (form 1) [6] and the Tinnitus Reaction Questionnaire [7]. Studies indicate that the degree of disability perceived by tinnitus patients, and its impact on the patient's quality of life, does not directly correlate with loudness, type of tinnitus, or length of time with tinnitus.

Concurrent mood disorders can increase the perception of disability. Increased tinnitus disability also has been demonstrated in patients with insomnia [8].

PATHOGENESIS — Tinnitus can be unilateral or bilateral and can be triggered anywhere along the auditory pathway (figure 1) [9]. It is believed to be encoded in neurons within the auditory cortex. The majority of patients have "sensorineural" tinnitus due to hearing loss at the cochlea or cochlear nerve level.

Somatic sounds may be perceived as tinnitus and originate in structures with proximity to the cochlea. These sounds are often generated in vascular structures but may also be produced by musculoskeletal structures. Somatic sounds are most often associated with pulsatile tinnitus and are typically unilateral. Continuous tonal tinnitus (single pure-tone) is usually not somatic in origin.

Pathogenetic theories postulate that the central nervous system is the source or "generator" of all tinnitus that does not have a somatic origin, even in patients whose associated hearing losses are due to cochlear injury [10]. Tinnitus generated by the central nervous system can be unilateral or bilateral, and the side of the tinnitus may not always correspond with the side of initial injury. Positron-emission tomography (PET) scanning and functional magnetic resonance imaging (MRI) studies indicate that the loss of cochlear input to neurons in the central auditory pathways (such as occurs with cochlear hair cell damage due to ototoxicity, noise trauma, or a lesion of the cochlear nerve) can result in abnormal neural activity in the auditory cortex. Such activity has been linked to the perception of tinnitus [11,12].

Another construct likens tinnitus to phantom pain perception that is thought to arise from a loss of suppression of neural activity [13-15]. Known neural feedback loops act to help tune and reinforce auditory memory in the central auditory cortex. Disruption of auditory input or the feedback loop may lead to the creation of alternative neural synapses and to loss of inhibition of normal synapses.

Tinnitus has also been likened to a type of auditory seizure [16], and antiseizure medications have had limited success in some patients [17]. Abnormal auditory-evoked magnetic field potentials associated with tinnitus can be suppressed in selected patients with intravenous lidocaine [18], confirming a central tinnitus phenomenon and potentially indicating a physiologic mechanism for lidocaine sensitive tinnitus. (See "Treatment of tinnitus", section on 'Medications'.)

Electrical stimulation, with round window electrodes or promontory stimulation, can suppress tinnitus in patients with profound hearing loss [19,20]. Electrical promontory stimulation may suppress abnormal spontaneous activity of cochlear nerve fibers; alternatively, it may provide background activity that acts to suppress abnormal central neural connections in patients with baseline sensorineural hearing loss and tinnitus. Cochlear implantation for hearing loss has had a secondary result of relieving tinnitus, with reported success for tinnitus improvement varying from 34 to 93 percent [21,22].

Many patients with tinnitus exhibit signs of anxiety and/or depression [23], and elevated serum serotonin levels have been found in some tinnitus patients [24]. Serotonin and gamma-aminobutyric acid (GABA) receptors are found throughout the auditory system, and neurotransmitter abnormalities may play a role in some patients with tinnitus [24-26].

These theories encompass disruption of normal neural firing patterns along the entire auditory pathway, from the end organ to the auditory cortex. They may explain tinnitus in patients who do not exhibit hearing loss, as well as in patients who recover from temporary hearing loss (eg, noise-induced hearing loss) but develop tinnitus that is persistent.

ETIOLOGY

Vascular disorders — Pulsatile tinnitus is most commonly, though not exclusively, vascular in etiology. Some vascular tinnitus, such as venous hums and tinnitus due to atherosclerotic plaque narrowing of vessels, can be non-pulsatile. Vascular tinnitus can be unilateral or bilateral; when bilateral, it is typically louder on the side of the pathology.

In a retrospective review of 84 patients with pulsatile tinnitus seen in a neurology department, 42 percent were found to have a significant vascular disorder (most commonly a dural arteriovenous fistula [AVF] or a carotid-cavernous sinus fistula) [27]. In 12 patients (14 percent), nonvascular disorders such as paraganglioma or intracranial hypertension (due to a variety of causes) explained the tinnitus.

Arterial bruits — Arterial vessels near the temporal bone may transmit sounds associated with turbulent blood flow, especially if the loudness of the sound exceeds the hearing threshold in that ear. The petrous carotid system is the most common source, although other arteries may also be involved [28]. An arterial bruit is not itself a serious condition, although the patient may require an evaluation for underlying atherosclerotic disease.

These patients usually do not have other otologic complaints (eg, hearing loss, vertigo, aural fullness). As with many other causes of tinnitus, their tinnitus is greatest in quiet environments (eg, at night).

Arteriovenous shunts — Congenital arteriovenous malformations (AVMs) are rarely associated with hearing loss or tinnitus. AVFs are more likely to be symptomatic, usually ipsilateral to the fistula. Dural AVFs are often associated with dural venous sinus thrombosis, which may occur spontaneously or be associated with infection, tumor, trauma, or surgery. Large dural AVFs can result in intracranial hemorrhage; early detection and treatment (surgery and/or vascular embolization) can be life-saving for high-grade lesions. (See "Nonaneurysmal subarachnoid hemorrhage".)

Paraganglioma — Head and neck paragangliomas are highly vascular, typically benign neoplasms arising from cells of the paraganglia that are found around the carotid bifurcation, within the jugular bulb, or along the tympanic arteries in the middle ear. Tympanic paragangliomas, previously known as glomus tympanicum tumors, and jugular bulb paragangliomas, commonly known as glomus jugulare, both commonly cause a loud pulsing tinnitus that may interfere with hearing. The tinnitus is typically unilateral, and the lesion may be visible through the tympanic membrane as a reddish or blue mass or may be palpable in the neck. As the tumor enlarges, it may cause hearing loss because of impingement on the ossicular chain (conductive loss) or the labyrinth or cochlea (sensorineural loss). Other cranial nerves may also be affected (eg, facial nerve or lower cranial nerve palsies). Paragangliomas of the head and neck are discussed separately. (See "Paragangliomas: Epidemiology, clinical presentation, diagnosis, and histology", section on 'Definition and anatomic origin' and "Paragangliomas: Epidemiology, clinical presentation, diagnosis, and histology", section on 'Head and neck paragangliomas'.)

Venous hums — These may be heard in patients with systemic hypertension, increased intracranial pressure (often due to pseudotumor cerebri) (see "Idiopathic intracranial hypertension (pseudotumor cerebri): Clinical features and diagnosis", section on 'Pulsatile tinnitus'), or in patients with a dehiscent or dominant jugular bulb (abnormally high placement of the jugular bulb). The latter may also cause a conductive hearing loss. Tinnitus in patients with a venous hum is often described as a soft, low-pitched hum that may decrease or stop with pressure over the jugular vein, with a change in head position, or with activity [28]. When tinnitus is due to asymmetry in the venous system, the tinnitus can be unilateral, or bilateral but louder on one side.

Neurologic disorders — Pulsatile tinnitus of muscular origin can result from spasm of one or both of the muscles within the middle ear (the tensor tympani and the stapedius muscle). These muscles are innervated by cranial nerves V and VII respectively. Such muscle spasms can occur spontaneously, because of local otologic disease, and also in the presence of neurologic disease such as multiple sclerosis. Patients may also complain of hearing loss or aural fullness associated with these muscle spasms. Tympanometry and otoscopy can be particularly useful in diagnosing middle ear spasmodic activity.

Clicking noises or irregular or rapid pulsations may also result from myoclonus of the palatal muscles that attach to the Eustachian tube orifice. Myoclonus of the palatal muscles most often is caused by an underlying neurologic abnormality, such as multiple sclerosis, microvascular disease affecting the brainstem, or neuropathy related to metabolic or toxic etiology; the history and physical examination should include a search for other neurologic disease.

Tinnitus due to myoclonus can be either unilateral or bilateral; when unilateral, symptoms are ipsilateral to the site of the muscle spasm.

Eustachian tube dysfunction — A patulous Eustachian tube can cause unilateral or bilateral tinnitus, with sounds similar to an ocean roar that may be synchronous with respiration [28]. It most commonly occurs after significant weight loss or after external beam radiation to or near the nasopharynx. The symptoms may disappear when the patient lies down. Patients can also complain of an unusual awareness of their own voice (autophony) and of ear discomfort. The cause of these symptoms is a Eustachian tube that remains abnormally patent, allowing too much and then too little aeration of the middle ear space with respiration. (See "Eustachian tube dysfunction", section on 'History'.)

Other somatic disorders — Somatic non-pulsatile tinnitus is commonly caused by temporomandibular joint (TMJ) dysfunction [29] and has also been associated with whiplash injuries [30] and other cervical-spinal disorders [31]. Tinnitus may improve when patients respond favorably to treatment for symptoms of TMJ dysfunction and craniocervical disease. The exact neurophysiologic mechanism for the generation of tinnitus from either the TMJ or the cervical spine is not known but may involve disinhibition of the dorsal cochlear nucleus [30]. In cases of somatic tinnitus, unilateral or bilateral symptoms may occur.

Tinnitus with a machine-like grinding or pulsing character is sometimes associated with intracranial lesions, such as chondrosarcoma, aberrant carotid artery, and endolymphatic sac tumors.

Tinnitus originating from the auditory system — Most tinnitus is due to a sensorineural hearing loss with resulting dysfunction within the auditory system. The auditory system includes the cochlear end organ, the cochlear nerve (with its projections to and from the cochlea), the brainstem (site of the cochlear nuclei), and the primary and secondary auditory cortical projections (figure 1).

Etiologies of tinnitus generated from within the auditory system are as varied as the types of noises that patients report (table 1). The presence of tinnitus often is an early indicator of cochlear hair cell dysfunction or loss, as in the case of prolonged noise exposure [32], Meniere disease (also characterized by aural fullness and vertigo), or ototoxicity. (See "Etiology of hearing loss in adults", section on 'Inner ear causes' and "Meniere disease: Evaluation, diagnosis, and management", section on 'Clinical presentation'.)

Ototoxic medications — Tinnitus is commonly caused by ototoxic medications (table 2); the ototoxicity typically affects both sides, causing bilateral symptoms. Ototoxicity affects the various components of the cochleovestibular end organ. When such structures are damaged, a change in neural firing between the end organ and the remainder of the auditory system can be exhibited by hearing loss, distortions in hearing, or tinnitus. (See "Etiology of hearing loss in adults", section on 'Ototoxic substances'.)

Presbycusis — Presbycusis (sensorineural hearing loss with aging) or any acquired high-frequency hearing loss is commonly associated with tinnitus (often described as a high-pitched ringing sound, crickets, or bells in the ear) along with the hearing loss. Cochlear hearing losses can be asymmetric, and even when symmetric they can result in unilateral or bilateral tinnitus. (See "Presbycusis", section on 'Tinnitus'.)

Otosclerosis — This is a condition of abnormal bone repair of the stapes footplate bone (third bone in the ossicular chain) and of the otic capsule. Tinnitus can result when otosclerosis damages cochlear structures. Progressive otosclerosis can result in fixation of the stapes footplate and worsening conductive hearing loss which can be unilateral or bilateral. (See "Etiology of hearing loss in adults", section on 'Otosclerosis'.)

Vestibular schwannoma — Tumors compressing or stretching the cochlear nerve can cause tinnitus. In addition, unilateral tinnitus can be the presenting sign of a schwannoma of the vestibular nerve within the cerebellar-pontine angle or the internal auditory canal (acoustic neuroma). (See "Vestibular schwannoma (acoustic neuroma)".)

Chiari malformations — Tinnitus, unilateral or bilateral, is one of the auditory signs associated with a symptomatic Chiari malformation and occurs when low-lying cerebellar tonsils causes tension on the auditory nerve [33]. Tinnitus from Chiari malformations can be both unilateral or bilateral.

Other etiologies — Hearing loss due to a variety of causes, including vascular ischemic events, infection, nerve compression, genetic predisposition, congenital hearing loss, or endocrine or metabolic damage to the auditory system, can produce tinnitus to a variable degree.

Tinnitus may occur with barotrauma to the middle or inner ear (often associated with vertigo and hearing loss) and with fluid in the middle ear (eg, with otitis media). (See "Etiology of hearing loss in adults" and "Acute otitis media in adults", section on 'Otitis media with effusion'.)

DIAGNOSIS — Tinnitus is frequently associated with hearing loss or other cochlear injury, and it may be the presenting complaint in a patient with a central nervous system lesion. History and physical examination are the first steps in establishing the etiology of tinnitus. Some patients may also warrant audiology examination, particularly those with unilateral tinnitus; although unilateral symptoms can direct aspects of the workup, it does not necessarily portend more worrisome diagnoses. Other tests, including imaging, are warranted in specific circumstances.

History — The history in patients with tinnitus should include a description of the tinnitus (episodic or constant, pulsatile or non-pulsatile, rhythmicity, pitch, quality of the sound), as well as inciting or alleviating factors. Patients should be asked about previous ear disease, noise exposure, hearing status, head injury, and symptoms suggesting temporomandibular joint (TMJ) syndrome. All medications and supplements should be reviewed. The history should review other medical conditions, including hypertension, atherosclerosis, neurologic illness, and prior surgery. Patients should be specifically asked about depression, anxiety, and insomnia, which can both exacerbate tinnitus and magnify its impact on quality of life. Patients complaining of tinnitus should also be asked if they have difficulty hearing or have noted a hearing loss.

Tinnitus that is distinctly pulsing or is described as rushing, flowing, or humming is usually vascular in origin. Patients often describe an increase in frequency and intensity with exercise, and some may recognize a connection with their pulse. Changes in intensity or pitch with head motion or body position (lying down versus sitting or standing) also strongly suggest a vascular tinnitus.

Clicking tinnitus almost always has a physiologic explanation. Myoclonus of the palatal muscles or middle ear structures can occur spontaneously but may also suggest significant neurologic disease. Some patients report a mechanical sounding tinnitus that is not tonal in nature. A diligent investigation searching for vascular or somatic causes is warranted for this rare complaint.

Tonal descriptions of tinnitus can help in the evaluation of a patient for a specific diagnosis or treatment.

A high-pitched continuous tone is by far the most commonly described type of tinnitus. High-pitched tinnitus is frequently a result of a sensorineural hearing loss or may suggest cochlear injury.

Low-pitched tinnitus is often seen in patients with Meniere disease, although it also can be idiopathic.

Physical examination — A complete head and neck examination, including cranial nerve examination and evaluation of the tympanic membrane, should be performed in all patients. Palatal myoclonus may be suppressed upon wide jaw opening; thus, its absence on oral examination does not rule out the diagnosis (nasopharyngoscopy may be indicated when suspicion is high).

In patients with suspected vascular tinnitus, auscultation over the neck, periauricular area, temple, orbit, and mastoid should be performed in various positions. The effects of positioning and vascular compression of the neck on the involved side should be noted. Tinnitus of venous origin can often be suppressed by careful pressure on the jugular vein.

Specialized testing

Suspected vascular tinnitus — Patients with infrequent episodes of pulsatile tinnitus or those with short-duration, mild tinnitus can be initially observed.

However, because frequent or constant pulsatile tinnitus can herald a potentially life-threatening illness, all of these patients require evaluation by an otolaryngologist or neurotologist. When physical examination does not reveal a specific vascular or musculoskeletal source in these patients, further investigation to rule out a central nervous system lesion such as a dural arteriovenous fistula (AVF), arteriovenous malformation (AVM) or aneurysm, or a skull base tumor should be carried out [34].

The gold standard for AVF diagnosing intracranial vascular lesions is angiography. These lesions often can also be diagnosed noninvasively with magnetic resonance (MR) angiography [35] or computed tomographic (CT) angiography [36]. High-resolution CT scanning is required to delineate the extent of involvement of the skull base if a paraganglioma is suspected and may be sufficient to evaluate other central nervous system lesions in selected patients. MRI can diagnose a Chiari malformation, vasculitis, central nervous system tumors, and multiple sclerosis and may indicate the presence of increased intracranial pressure (such as that seen in pseudotumor cerebri) or tumors. Many patients require both contrast MRI and contrast CT because of the varied nature of disorders that cause pulsatile tinnitus. If both of these studies are normal, and suspicion for a vascular lesion remains high, angiography or MR angiography is warranted.

Our protocol involves audiometric testing followed by an extensive history and physical exam, which guides additional diagnostic testing. When an intracranial vascular lesion is suspected, we obtain an MRI with contrast initially, followed by CT/CT angiography and subsequent interventional angiography in appropriate circumstances.

Suspected auditory system tinnitus — For patients with tinnitus associated with hearing loss or a change in hearing, audiometric tests may help determine if the tinnitus originates within the auditory system and are essential in the evaluation. Any patient with constant unilateral or bilateral tinnitus persistent for six months or more should also be referred for a formal audiology evaluation [37].

Initial audiometric tests should include a pure-tone audiogram, tympanometry, auditory reflex testing, determination of speech discrimination abilities, and otoacoustic emissions testing. These tests identify asymmetries between the two ears and indicate abnormalities in the middle ear, cochlea, and brainstem; as well, they can define the site of abnormality within the auditory system or confirm normal functioning. Such testing is performed in an audiologist's office, ideally one affiliated with an otolaryngology department or practice.

Asymmetry in hearing function, reflex testing, or otoacoustic emissions, in patients with no identified otologic abnormality, should be followed-up with auditory brainstem response testing (ABR) and imaging studies (eg, MRI) to rule out inner ear anomalies, central nervous system lesions, and neurologic disease. Further workup may involve neurologic or neurosurgical consultation, endocrine evaluation, or angiography.

SOCIETY GUIDELINE LINKS — Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See "Society guideline links: Hearing loss and hearing disorders in adults".)

INFORMATION FOR PATIENTS — UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5th to 6th grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10th to 12th grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.

Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)

Basics topic (see "Patient education: Tinnitus (ringing in the ears) (The Basics)")

Beyond the Basics topic (see "Patient education: Tinnitus (ringing in the ears) (Beyond the Basics)")

SUMMARY AND RECOMMENDATIONS

Epidemiology – Tinnitus affects 50 million people in the United States and interferes with daily activity in a quarter of those affected. Prevalence is greater in men and increases with age. (See 'Epidemiology' above.)

Pulsatile tinnitus – Pulsatile tinnitus is most commonly vascular in origin and requires thorough evaluation.

Vascular tinnitus can be unilateral or bilateral; when bilateral, it is typically louder on the side of the pathology. Differential diagnosis includes intracranial arteriovenous malformation (AVM), arteriovenous fistula (AVF), arterial bruit, and paraganglioma. (See 'Vascular disorders' above.)

Clicking pulsatile tinnitus may indicate a neurologic disorder causing myoclonus of palatal muscles or of the muscles in the inner ear. Tinnitus can be either unilateral or bilateral; when unilateral, symptoms are ipsilateral to the site of the muscle spasm. (See 'Neurologic disorders' above.)

Etiology – Tinnitus most commonly is a result of abnormalities within the auditory system, often with unexplained etiology. It may be associated with sensorineural hearing loss, ototoxic medications, infection, vascular ischemia, or acoustic neuroma. (See 'Tinnitus originating from the auditory system' above.)

Pathogenesis – All sensorineural tinnitus is believed to be generated within the central nervous system, with cochlear abnormalities leading to loss of inhibition of cortical auditory neurons. Serotonergic neurotransmitters may play a role. (See 'Pathogenesis' above.)

Evaluation

Evaluation of tinnitus should include a thorough history, an examination including auscultation for bruits in patients with possible vascular tinnitus, and a complete head and neck examination in all patients. (See 'Diagnosis' above.)

Patients with pulsatile tinnitus, other than those with infrequent intermittent symptoms, should have otolaryngologic investigation and may require contrast computed tomography (CT) scanning, contrast magnetic resonance (MR) scanning, and/or angiography. (See 'Suspected vascular tinnitus' above.)

For patients with tinnitus suspected of arising within the auditory system, and for those with unilateral tinnitus, audiometric testing is indicated. (See 'Suspected auditory system tinnitus' above.)

  1. Shargorodsky J, Curhan GC, Farwell WR. Prevalence and characteristics of tinnitus among US adults. Am J Med 2010; 123:711.
  2. Shetye A, Kennedy V. Tinnitus in children: an uncommon symptom? Arch Dis Child 2010; 95:645.
  3. Adams PF, Hendershot GE, Marano MA, Centers for Disease Control and Prevention/National Center for Health Statistics. Current estimates from the National Health Interview Survey, 1996. Vital Health Stat 10 1999; :1.
  4. Ahmad N, Seidman M. Tinnitus in the older adult: epidemiology, pathophysiology and treatment options. Drugs Aging 2004; 21:297.
  5. Stouffer JL, Tyler RS. Characterization of tinnitus by tinnitus patients. J Speech Hear Disord 1990; 55:439.
  6. Newman CW, Sandridge SA, Jacobson GP. Psychometric adequacy of the Tinnitus Handicap Inventory (THI) for evaluating treatment outcome. J Am Acad Audiol 1998; 9:153.
  7. Wilson PH, Henry J, Bowen M, Haralambous G. Tinnitus reaction questionnaire: psychometric properties of a measure of distress associated with tinnitus. J Speech Hear Res 1991; 34:197.
  8. Folmer RL, Griest SE, Meikle MB, Martin WH. Tinnitus severity, loudness, and depression. Otolaryngol Head Neck Surg 1999; 121:48.
  9. Minen MT, Camprodon J, Nehme R, Chemali Z. The neuropsychiatry of tinnitus: a circuit-based approach to the causes and treatments available. J Neurol Neurosurg Psychiatry 2014; 85:1138.
  10. Qiu C, Salvi R, Ding D, Burkard R. Inner hair cell loss leads to enhanced response amplitudes in auditory cortex of unanesthetized chinchillas: evidence for increased system gain. Hear Res 2000; 139:153.
  11. Melcher JR, Sigalovsky IS, Guinan JJ Jr, Levine RA. Lateralized tinnitus studied with functional magnetic resonance imaging: abnormal inferior colliculus activation. J Neurophysiol 2000; 83:1058.
  12. Lockwood AH, Salvi RJ, Coad ML, et al. The functional neuroanatomy of tinnitus: evidence for limbic system links and neural plasticity. Neurology 1998; 50:114.
  13. Lockwood AH, Salvi RJ, Burkard RF, et al. Neuroanatomy of tinnitus. Scand Audiol Suppl 1999; 51:47.
  14. Møller AR. Similarities between chronic pain and tinnitus. Am J Otol 1997; 18:577.
  15. Mühlnickel W, Elbert T, Taub E, Flor H. Reorganization of auditory cortex in tinnitus. Proc Natl Acad Sci U S A 1998; 95:10340.
  16. Shulman A, Goldstein B. Medical Significance of Tinnitus. Int Tinnitus J 1997; 3:45.
  17. Sanchez TG, Balbani AP, Bittar RS, et al. Lidocaine test in patients with tinnitus: rationale of accomplishment and relation to the treatment with carbamazepine. Auris Nasus Larynx 1999; 26:411.
  18. Shiomi Y, Nagamine T, Fujiki N, et al. Tinnitus remission by lidocaine demonstrated by auditory-evoked magnetoencephalogram. A preliminary report. Acta Otolaryngol 1997; 117:31.
  19. Portmann M, Cazals Y, Negrevergne M, Aran JM. Temporary tinnitus suppression in man through electrical stimulation of the cochlea. Acta Otolaryngol 1979; 87:294.
  20. Matsushima JI, Fujimura H, Sakai N, et al. A study of electrical promontory stimulation in tinnitus patients. Auris Nasus Larynx 1994; 21:17.
  21. Ito J. Tinnitus suppression in cochlear implant patients. Otolaryngol Head Neck Surg 1997; 117:701.
  22. Miyamoto RT, Bichey BG. Cochlear implantation for tinnitus suppression. Otolaryngol Clin North Am 2003; 36:345.
  23. Holgers KM, Zöger S, Svedlund K. Predictive factors for development of severe tinnitus suffering-further characterisation. Int J Audiol 2005; 44:584.
  24. Simpson JJ, Davies WE. A review of evidence in support of a role for 5-HT in the perception of tinnitus. Hear Res 2000; 145:1.
  25. Thompson GC, Thompson AM, Garrett KM, Britton BH. Serotonin and serotonin receptors in the central auditory system. Otolaryngol Head Neck Surg 1994; 110:93.
  26. Woods CI, Azeredo WJ. Noradrenergic and serotonergic projections to the superior olive: potential for modulation of olivocochlear neurons. Brain Res 1999; 836:9.
  27. Waldvogel D, Mattle HP, Sturzenegger M, Schroth G. Pulsatile tinnitus--a review of 84 patients. J Neurol 1998; 245:137.
  28. Fortune DS, Haynes DS, Hall JW 3rd. Tinnitus. Current evaluation and management. Med Clin North Am 1999; 83:153.
  29. Ren YF, Isberg A. Tinnitus in patients with temporomandibular joint internal derangement. Cranio 1995; 13:75.
  30. Levine RA. Somatic (craniocervical) tinnitus and the dorsal cochlear nucleus hypothesis. Am J Otolaryngol 1999; 20:351.
  31. Montazem A. Secondary tinnitus as a symptom of instability of the upper cervical spine: operative management. Int Tinnitus J 2000; 6:130.
  32. Griest SE, Bishop PM. Tinnitus as an early indicator of permanent hearing loss. A 15 year longitudinal study of noise exposed workers. AAOHN J 1998; 46:325.
  33. Albers FW, Ingels KJ. Otoneurological manifestations in Chiari-I malformation. J Laryngol Otol 1993; 107:441.
  34. Mundada P, Singh A, Lingam RK. CT arteriography and venography in the evaluation of Pulsatile tinnitus with normal otoscopic examination. Laryngoscope 2015; 125:979.
  35. Dietz RR, Davis WL, Harnsberger HR, et al. MR imaging and MR angiography in the evaluation of pulsatile tinnitus. AJNR Am J Neuroradiol 1994; 15:879.
  36. Forsting M. CTA of the ICA bifurcation and intracranial vessels. Eur Radiol 2005; 15 Suppl 4:D25.
  37. Tunkel DE, Bauer CA, Sun GH, et al. Clinical practice guideline: tinnitus executive summary. Otolaryngol Head Neck Surg 2014; 151:533.
Topic 6855 Version 37.0

References